Skip to main content

Cellway Ventures Changes Name to Acrongenomics

NEW YORK, March 5 (GenomeWeb News) - Cellway Ventures has changed its name to Acrongenomics, the company said today.


The company, based in Calgary, Canada, said it changed its name "to more accurately reflect its emerging business." Its symbol on the Over The Counter Bulletin Board will change from CWYV to AGNM.


Earlier this year, the company said it is negotiating to acquire a European pharmaceutical company and patents and rights to a predictive molecular diagnostic test for metastatic cancer from European scientists.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.